In recent years, progress in biomedical research and technology has provided unprecedented opportunities to explore new therapies that — when used on their own or in combination with other types of treatment — might prevent or slow the progression of tumors by harnessing the inherent antitumor activities of a patient’s immune system.

The Ludwig Center for Cancer Immunotherapy promotes and facilitates the integration of laboratory and clinical investigation of such immunotherapies through a number of activities, for example by:

• Developing experimental immunotherapy strategies in preclinical models
• Translating such therapies from preclinical investigation to clinical application
• Monitoring immune responses in cancer patients as a means to improve the understanding of basic mechanisms by which cells of the immune system respond to tumors
• Analyzing clinical data to inform basic and translational research